BridgeBio Pharma (BBIO) Interest & Investment Income (2018 - 2026)
BridgeBio Pharma recorded quarterly Interest & Investment Income of $6.2 million in Q1 2026, up 44.18% quarter-over-quarter from $4.3 million in Q4 2025, and up 15.99% year-over-year from $5.4 million in Q1 2025.
BridgeBio Pharma's Interest & Investment Income history runs 9 years deep, the most recent figure standing at $6.2 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 15.99% year-over-year to $6.2 million; the TTM figure through Mar 2026 stood at $20.7 million (up 11.62% YoY), while the FY2025 annual figure was $19.9 million, up 15.1% from the prior year.
- Interest & Investment Income came in at $6.2 million for Q1 2026 at BridgeBio Pharma, up from $4.3 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $6.2 million in Q1 2026 to a low of $267000.0 in Q1 2022.
- A 5-year average of $4.1 million and a median of $4.2 million in 2023 frame the typical range for Interest & Investment Income.
- On a YoY basis, Interest & Investment Income climbed as much as 2148.35% in 2022 and fell as far as 32.23% in 2022.
- BridgeBio Pharma's Interest & Investment Income stood at $4.1 million in 2022, then soared by 36.31% to $5.6 million in 2023, then decreased by 16.05% to $4.7 million in 2024, then dropped by 7.5% to $4.3 million in 2025, then soared by 44.18% to $6.2 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $6.2 million, $4.3 million, and $6.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | 6.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.25 Mn |
| Dec 31, 2025 | 4.33 Mn |
| Sep 30, 2025 | 6.24 Mn |
| Jun 30, 2025 | 3.90 Mn |
| Mar 31, 2025 | 5.39 Mn |
| Dec 31, 2024 | 4.68 Mn |
| Sep 30, 2024 | 3.30 Mn |
| Jun 30, 2024 | 5.20 Mn |
| Mar 31, 2024 | 4.08 Mn |
| Dec 31, 2023 | 5.58 Mn |
| Sep 30, 2023 | 3.79 Mn |
| Jun 30, 2023 | 4.51 Mn |
| Mar 31, 2023 | 4.15 Mn |
| Dec 31, 2022 | 4.09 Mn |
| Sep 30, 2022 | 2.42 Mn |
| Jun 30, 2022 | 766,000.00 |
| Mar 31, 2022 | 267,000.00 |
| Dec 31, 2021 | 182,000.00 |
| Sep 30, 2021 | 234,000.00 |
| Jun 30, 2021 | 323,000.00 |
| Mar 31, 2021 | 394,000.00 |
| Dec 31, 2020 | 448,000.00 |
| Sep 30, 2020 | 692,000.00 |
| Jun 30, 2020 | 934,000.00 |
| Mar 31, 2020 | 1.94 Mn |
| Dec 31, 2019 | 2.41 Mn |
| Sep 30, 2019 | 2.74 Mn |
| Jun 30, 2019 | 1.66 Mn |
| Mar 31, 2019 | 2.11 Mn |
| Dec 31, 2018 | 1.47 Mn |
| Sep 30, 2018 | 528,000.00 |
| Jun 30, 2018 | 2,000.00 |